MedTrace Logo

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

NCT01540994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-01-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate a short course (five radiation treatments) of very focused ("stereotactic") external beam radiation therapy for the treatment of early stage prostate cancer.

Conditions

  • Prostatic Neoplasm

Interventions

RADIATION

Radiation Therapy

Stereotactic Body Radiation Therapy

Sponsors & Collaborators

  • Sharp HealthCare

    lead OTHER

Principal Investigators

  • Geoffrey Weinstein, M.D. · Sharp HealthCare

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2019-04-05
Completion
2019-04-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01540994 on ClinicalTrials.gov